Heart & Vascular

Photo: FinisherPix Gina’s heart “paused” twice while she was in the ER with one of the longest atrial fibrillation (Afib) episodes she had ever experienced. It was 2022, and a newly FDA-approved dual chamber leadless (wireless) pacemaker was available through a clinical trial in only a few select sites across the country. Thankfully for Gina, … Read More

Heather shares her story of surviving an aortic dissection and how she supports other survivors who have experienced the same.

Hear how Jean survived and thrived following an aortic emergency at the Jeffrey M. Carlton Heart & Vascular Institute at Hoag.

Semaglutide, the active ingredient in the diabetes and weight loss medications Ozempic and Wegovy was in the spotlight last year for its role in celebrity diet crazes. But this drug seems to have something other Hollywood fads don’t: data backing it up. In a large international study, semaglutide was found to reduce the risk of … Read More

Heart disease is the number one killer in the U.S., but each one of us has the power to stop this killer in its tracks. “Reducing the risk factors associated with heart disease can dramatically reduce an individual’s risk of experiencing a cardiovascular event,” said John Nan M.D., interventional cardiologist with the Jeffrey M. Carlton … Read More

With holiday stress bursting like Santa’s sleigh and diet goals drowning in eggnog, it is little wonder that more people die from heart attacks during the last week of December than at any other time of the year. “With routines disrupted, people tend to eat and drink more and exercise and sleep less. Coupled with … Read More

 NEWPORT BEACH, Calif. (Nov. 29, 2023) – Hoag’s Jeffrey M. Carlton Heart and Vascular Institute has earned the highest distinction possible, a three-star rating out of three stars, from the Society of Thoracic Surgeons (STS) for three categories of surgery – isolated aortic valve replacement (AVR), isolated mitral valve replacement and repair (MVRR) and isolated … Read More

Two of Orange County’s biggest hospitals, Hoag Memorial Hospital Presbyterian and Providence St. Joseph in Orange, today touted successful implants of the world’s first dual chamber leadless pacemaker in a patient. The FDA recently approved the Aveir DR, the world’s first dual chamber leadless pacemaker system made by medtech giant Abbott Laboratories. Newport Beach’s Hoag … Read More

Jerry Kelleher knew that one day he’d need a pacemaker. His cardiologists over the years had warned him as much. But what he couldn’t have known was that when the time came, he’d be excited about it. “I was thrilled to be part of the clinical trial at Hoag,” Kelleher, 71, said of the world’s … Read More

NEWPORT BEACH, Calif. (Nov. 7, 2023) – Hoag Memorial Hospital Presbyterian announced the successful implant of the world’s first dual chamber leadless pacemaker in a patient. The minimally invasive surgery was a success and marks a new era in cardiac care. The FDA recently approved the AVEIR™ DR, the world’s first dual chamber leadless pacemaker … Read More